Literature DB >> 19202966

Diagnosis and treatment of osteoporosis.

Mary Gayle Sweet1, Jon M Sweet, Michael P Jeremiah, Sim S Galazka.   

Abstract

Osteoporosis affects approximately 8 million women and 2 million men in the United States. The associated fractures are a common and preventable cause of morbidity and mortality in up to 50 percent of older women. The U.S. Preventive Services Task Force recommends using dual energy x-ray absorptiometry to screen all women 65 years and older and women 60 to 64 years of age who have increased fracture risk. Some organizations recommend considering screening in all men 70 years and older. For persons with osteoporosis diagnosed by dual energy x-ray absorptiometry or previous fragility fracture, effective first-line treatment consists of fall prevention, adequate intake of calcium (at least 1,200 mg per day) and vitamin D (at least 700 to 800 IU per day), and treatment with a bisphosphonate. Raloxifene, calcitonin, teriparatide, or hormone therapy maybe considered for certain subsets of patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19202966

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  29 in total

1.  An unusual presentation of amyloidosis.

Authors:  Girish Bathla; Erica Savage; Michele Fang
Journal:  J Gen Intern Med       Date:  2014-11-15       Impact factor: 5.128

2.  The effect of physician workload on an educational intervention to increase vitamin D screening.

Authors:  Heather Kramm; Ronald Gangnon; Andrea N Jones; Mark Linzer; Karen E Hansen
Journal:  WMJ       Date:  2010-06

3.  Three-dimensional external beam radiotherapy for prostate cancer increases the risk of hip fracture.

Authors:  Sean P Elliott; Stephanie L Jarosek; Shaheen R Alanee; Badrinath R Konety; Kathryn E Dusenbery; Beth A Virnig
Journal:  Cancer       Date:  2011-03-16       Impact factor: 6.860

4.  Treadmill training prevents bone loss by inhibition of PPARγ expression but not promoting of Runx2 expression in ovariectomized rats.

Authors:  Yongjie Chen; Shouhui Wang; Shumin Bu; Yingjie Wang; Yushuang Duan; Shaofeng Yang
Journal:  Eur J Appl Physiol       Date:  2011-01-09       Impact factor: 3.078

Review 5.  Osteoporosis--a risk factor for cardiovascular disease?

Authors:  Christos E Lampropoulos; Ioanna Papaioannou; David P D'Cruz
Journal:  Nat Rev Rheumatol       Date:  2012-08-14       Impact factor: 20.543

6.  SHP2 regulates osteoclastogenesis by promoting preosteoclast fusion.

Authors:  Yi Zhou; Aron Mohan; Douglas C Moore; Liangjun Lin; Frank Li Zhou; Jay Cao; Qian Wu; Yi-Xian Qin; Anthony M Reginato; Michael G Ehrlich; Wentian Yang
Journal:  FASEB J       Date:  2015-01-15       Impact factor: 5.191

Review 7.  Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER.

Authors:  Eric R Prossnitz; Matthias Barton
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-05-13       Impact factor: 3.072

Review 8.  A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.

Authors:  John A Kanis; Nicholas C Harvey; Cyrus Cooper; Helena Johansson; Anders Odén; Eugene V McCloskey
Journal:  Arch Osteoporos       Date:  2016-07-27       Impact factor: 2.617

9.  Osteoporosis screening: mixed messages in primary care.

Authors:  Margaret Gourlay
Journal:  Am Fam Physician       Date:  2009-02-01       Impact factor: 3.292

10.  Overexpression of integrin a2 promotes osteogenic differentiation of hBMSCs from senile osteoporosis through the ERK pathway.

Authors:  Hui-Min Hu; Liu Yang; Zhe Wang; Yan-Wu Liu; Jin-Zhu Fan; Jing Fan; Jian Liu; Zhuo-Jing Luo
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.